With so many independent papers continually produced about 'CS1' I'll admit to becoming a little complacent about 'just another research paper referring to the capabilities of bisantrene'.
Time to wake up myself up.
Just how often do you see a biotech's lead asset described as 'drastically' impacting cancer cells (or similar)?
Seriously.
In fact, the question could probably be asked better....
'Just how often do you see another biotech's lead asset described as 'drastically' impacting cancer cells (or similar)....by multiple, unrelated, independent research organisations that have no commercial benefit in promoting that lead asset?'
Then consider none of them are even reporting on CPACS yet.
I truly hope that some of the $2M saving on trials will be put towards hiring a gun legal team; BP will not sign-off on $B unless their sharpest negotiation and legal minds are all over it. Grads need not apply.
I never doubted the science; the reasons why I changed sentiment from 'buy' to 'hold' had more to do with what went on outside of the lab.
I've seen enough in recent times to change sentiment from 'hold' to 'buy'. Good work @RaceOncology.
- Forums
- ASX - By Stock
- Pillar 1 - FTO (new thread)
With so many independent papers continually produced about 'CS1'...
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.69 |
Change
0.000(0.00%) |
Mkt cap ! $288.0M |
Open | High | Low | Value | Volume |
$1.66 | $1.69 | $1.57 | $387.6K | 237.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 807 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.69 | 2376 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 807 | 1.630 |
1 | 4000 | 1.600 |
2 | 2300 | 1.580 |
1 | 636 | 1.570 |
1 | 6000 | 1.560 |
Price($) | Vol. | No. |
---|---|---|
1.690 | 2376 | 1 |
1.735 | 3313 | 1 |
1.750 | 2000 | 1 |
1.790 | 1000 | 1 |
1.800 | 2000 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
RAC (ASX) Chart |